Thomas Flaten
Stock Analyst at Lake Street
(0.93)
# 2185
Out of 5,368 analysts
46
Total ratings
40.00%
Success rate
8.06%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OCX OncoCyte | Maintains: Strong Buy | 5 8 | 2.67 | 199.63% | 6 | May 21, 2025 | |
BDSX Biodesix | Maintains: Buy | 3 2 | n/a | n/a | 1 | May 14, 2025 | |
CSTL Castle Biosciences | Maintains: Buy | 40 35 | 18.77 | 86.47% | 6 | May 6, 2025 | |
OPTN OptiNose | Downgrades: Hold | 17 9 | n/a | n/a | 5 | Mar 20, 2025 | |
CKPT Checkpoint Therapeut... | Downgrades: Hold | 7 5 | n/a | n/a | 5 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 3.42 | 133.92% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 6 | 2.77 | 116.61% | 2 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 9 | 6 | 50% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 6.8 | 32.35% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.63 | 376.19% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 3.25 | 238.46% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 22 | 13.64% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 2.05 | 70143.9% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 8 | 3.66 | 118.58% | 1 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |